FutuRx is a biotech incubator founded by three leading global healthcare players – Takeda (Takeda Ventures Inc.), Johnson & Johnson (JJDC), and OrbiMed Israel Partners. By combining the expertise of its management and the capabilities of its founders, FutuRx provides a unique model for the transformation of breakthrough discoveries into novel medicines. FutuRx leverages its access to the Israeli biotech industry, and to leading research institutes in Israel and worldwide, to identify and develop highly innovative technologies. Experts at Takeda, J&J, and OrbiMed are deeply involved in the project selection process and during the incubator period of each company. The result is a clear impact on the efficient translation of innovative research to clinically meaningful products.
View Top Employees from FutuRx| Website | http://www.futurx.co.il |
| Revenue | $5 million |
| Employees | 31 (31 on RocketReach) |
| Founded | 2014 |
| Address | 2 Ilan Ramon St, Ness Ziona 7403635, IL |
| Phone | +972 8-955-3100 |
| Fax | +972 8-955-3111 |
| Industry | Biotechnology, Business Services General, Microbiome, Business Services, Science and Engineering, Phage therapy, Manufacturing, Microbiology, Pharmaceutical, Health Care |
| Web Rank | 10 Million |
| Keywords | Futurx, Pink Biopharma Ltd., Xonovo, Pi Terapuetics, Mabtrix |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular FutuRx employee's phone or email?
FutuRx Questions
The FutuRx annual revenue was $5 million in 2024.
Liana Patt is the CEO of FutuRx.
31 people are employed at FutuRx.
The NAICS codes for FutuRx are [325, 32541, 32, 3254].
The SIC codes for FutuRx are [283, 28].
Top FutuRx Employees
-
2
-
1
-
11
-
ViewInbal Michailovici
Director of Business Development at FutuRx
Rehovot, Central District, Israel2
Related Companies
